Thursday, March 14, 2013
Publication and contact
Mucosal delivery to improve
cancer vaccine efficacy
Mouse studies suggest
cancer vaccines formulated for mucosal delivery could have better efficacy
against mucosal tumors than vaccines delivered via subcutaneous injection. In
orthotopic mouse models for mucosal tissue head and neck cancers, an
intranasal formulation of a Shiga toxin-based cancer vaccine decreased tumor
growth and increased survival compared with an analogous cancer vaccine
formulated for intramuscular delivery. In the mouse models, the intranasal
vaccine formulation induced a stronger antigen-specific CD8+ T cell response in the mucosa than the
intramuscular formulation. Next steps include developing an intranasal
formulation of an existing vaccine for mucosal delivery and then evaluating
it in a clinical trial against an analogous vaccine delivered via
Published online March 14, 2013
Work unpatented; cancer
vaccine tested in study patented; licensing details available from the Curie Institute's Technology
Sandoval, F. et al. Sci.
Transl. Med.; published online Feb. 13, 2013;
Contact: Eric Tartour, Institut National de la Santé et de
la Recherche Médicale (INSERM), Paris, France
Contact: Federico Sandoval,
same affiliation as above
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]